Innate Pharma to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Businesswire12/20 14:00

ADRs Close Lower; Innate Pharma S.A. Declines 22%

Dow Jones12/17 05:31

Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket

Benzinga12/16 19:37

ADRs End Higher; WISeKey International Holding Ltd. Climbs 139%

Dow Jones12/14 05:31

Innate Pharma Shares Are Trading Higher After the Company Announced Its TELLOMAK Phase 2 Trial of Lacutamab Demonstrated Significant Symptom Relief and Quality of Life Improvements.

Benzinga12/09 20:59

HC Wainwright & Co. Reiterates Buy on Innate Pharma, Maintains $11.5 Price Target

Benzinga12/09 19:30